Navigation Links
Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
Date:9/1/2009

tatements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, including (without limitation) velaglucerase alfa, as well as the ability to secure and integrate new products for commercialization and/or development; government regulation of the Company's products; the Company's ability to manufacture its products in sufficient quantities to meet demand; the impact of competitive therapies on the Company's products; the Company's ability to register, maintain and enforce patents and other intellectual property rights relating to its products; the Company's ability to obtain and maintain government and other third-party reimbursement for its products; and other risks and uncertainties detailed from time to time in the Company's filings with the Securities and Exchange Commission.

    For further information please contact:

    Investor Relations Clea Rosenfeld (Rest of the World) +44-1256-894-160
                       Eric Rojas (North America)          +1-617-551-9715

    Media              Jessica Mann (Rest of the World)   +44-1256-894-280
                       Jessica Cotrone (North America)     +1-617-613-4640



'/>"/>
SOURCE Shire Plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
2. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
3. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
4. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
5. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
6. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
7. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
8. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
9. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
10. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
11. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... September 2, 2015 According to ... Product (Digital & Computed Radiography, Ultrasound, Computed & Optical ... by Application (Oncology, Cardiology, Neurology) - Global Forecast to ... reach USD 2.8 Billion by 2020 growing at a ... Br owse 240 Tables and 44 F ...
(Date:9/2/2015)... ROCKVILLE, Md. , Sept. 2, 2015 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... J.J. Finkelstein , President and Chief Executive ... Rodman & Renshaw Global Investment Conference, sponsored by ... will be held September 8-10, 2015 at the ...
(Date:9/2/2015)... 2, 2015  Valeant Pharmaceuticals International, Inc. (NYSE: ... affiliate has entered into a definitive agreement under which ... Inc. (NASDAQ: SURG ) for $6.50 per share ... Synergetics stockholders will receive additional cash payments of up ... achieved following the closing.  The transaction is expected to ...
Breaking Medicine Technology:Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5
... N.J., Oct. 27 Savient Pharmaceuticals, Inc. (Nasdaq: ... results for the third quarter 2010 following the close of ... Paul Hamelin, President, and David Gionco, Group Vice President, Chief ... call beginning at 9:00 a.m. Eastern Time on Friday, November ...
... 27 Express Scripts, Inc. (Nasdaq: ESRX ) announced ... or $0.57 per diluted share.  Third quarter adjusted earnings per share, ... increase of 55% over 2009. Third Quarter ... Tables 2 and 3) Total adjusted claims of ...
Cached Medicine Technology:Savient Pharmaceuticals to Hold Third Quarter 2010 Financial Results Conference Call on Friday, November 5, 2010 2Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 2Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 3Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 4Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 5Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 6Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 7Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 8Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 9Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 10Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 11Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 12Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 13Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 14Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 15Express Scripts Announces Record Third Quarter Earnings and 2011 Guidance 16
(Date:9/2/2015)... ... ... Amada Senior Care, premier provider of in-home care and assisted living placement ... location. Amada franchise partners Mike and Mell Fleming came to the senior care industry ... years in medical device sales while Mell spent over 30 years as a registered ...
(Date:9/2/2015)... ... September 02, 2015 , ... SonicSurg ... extremity surgical market, announced today that more than 600 successful patient procedures have ... hand. Plus, nearly 70 of these procedures have been on triggering thumbs. ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... records and case management solutions and services to both government and commercial clients, ... and Image Clean-up utility for IBM’s Datacap document capture platform. EDAC PurePAGE ...
(Date:9/2/2015)... ... September 02, 2015 , ... On September 9, 2015, ... doTERRA’s annual convention, the largest single-company convention to date for the state of Utah. ... forward to a tremendous event,” states David Stirling, doTERRA CEO. “One of the most ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was featured ... coolest technology products available to consumers. Amanda Forstrom, a technology expert and special reporter ... for people to comfortably hold a tablet while reducing the likelihood of it dropping. ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:Trigger Tome Surpasses 600 Successful Patient Procedures 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:doTERRA to Host the Largest Single-Company Convention in the State of Utah 2Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2
... Democratic leadership and State delegations as a possible solution to national ... ... 29, 2008 -- If there has been any one consistent message ... been the party platform initiative to resolve our national health care ...
... online financial planning calculators available to people with disabilities. , ... ... to move forward after a diagnosis of a long-term disability is ... as they can to understand their financial options, according to ...
... and local government clients to engage via GSA. , ... ... emerging software engineering firm dedicated to the life sciences, announced ... GSA IT Schedule 70 provides government customers with the ability to ...
... found , , THURSDAY, Aug. 28 (HealthDay News) -- Working ... for people who have survived a stroke and gone ... , "You address two problems these patients have," said ... neurology and neurorehabilitation at the University of Zurich in ...
... VIEW, Calif., Aug. 28 The 2008 European,Hemodialysis Emerging ... in recognition of its pioneering Redsense -- a unique ... during hemodialysis,and may save the lives of many patients"., ... sensor patch. The sensor is,connected to the alarm using ...
... Aug. 28 ISTA Pharmaceuticals,Inc. (Nasdaq: ISTA ... Thomas Weisel,Partners Healthcare Conference at 11:30 a.m. Eastern ... Seasons Hotel in Boston, MA., ISTA,s President ... provide an update on the Company,s commercial and ...
Cached Medicine News:Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Federal and State Agencies Have Easier Access to 5AM Solutions' Award-Winning Software Services 2Health News:Treadmill Workouts Help Stroke Survivors 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3
... Vascular Graft, the newest vascular graft offering ... leader in vascular surgical products for more ... reducing kinking and compression problems that ... graft provides all of the benefits of ...
... rasping necessary in cruciate ligament reconstruction procedures ... bone surface. This condition, if not rectified ... cruciate replacement. The GORE SMOOTHER Crucial Tool ... procedures. The tool functions as both a ...
Vikingselect™ Intra-Operative Monitoring (IOM)....
... system has been designed by practicing ... of the ever changing and demanding ... analyzing data from multiple modalities, including: ... and multiple patients at multiple sites. ...
Medicine Products: